2012
DOI: 10.1016/j.gene.2012.05.036
|View full text |Cite
|
Sign up to set email alerts
|

Possible therapeutic effects of myxobacterial metabolites on type I Gaucher disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 19 publications
(17 reference statements)
0
2
0
Order By: Relevance
“…Lipid extraction and GluCer separation were performed as described in a previous article. 9) Densitometric analysis was carried out to measure GluCer levels with TINA 2.0 software (Raytest Isotopenmessgeräte GmbH, Straubenhardt, Germany).…”
Section: Methodsmentioning
confidence: 99%
“…Lipid extraction and GluCer separation were performed as described in a previous article. 9) Densitometric analysis was carried out to measure GluCer levels with TINA 2.0 software (Raytest Isotopenmessgeräte GmbH, Straubenhardt, Germany).…”
Section: Methodsmentioning
confidence: 99%
“…Quantitative changes in GluCer levels for cells treated with resveratrol or DMSO (vehicle control) were evaluated by thin‐layer chromatography (TLC). Lipid extraction and GluCer separation were carried out as described in our previous article (Kim et al, ). Densitometric analysis was performed to examine GluCer levels with TINA 2.0 software (Raytest Isotopenmessgeräte GmbH).…”
Section: Methodsmentioning
confidence: 99%